Swiss drugmaker Roche predicted on April 21 that demand for the company's drugs would accelerate for the remainder of 2021, after first-quarter sales of Covid-19 tests...
It's normal for different people to mount stronger or weaker immune responses to a vaccine, but post-shot side effects won't tell you which you are.
It's normal for different people to mount stronger or weaker immune responses to a vaccine, but post-shot side effects won't tell you which you are.
The EMA has started reviewing the emergency use application for GlaxoSmithKline and Vir Biotech’s COVID-19 antibody VIR-7831, which The post EMA starts review of GSK/Vir COVID-19...
UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last The post Clive Dix: Rebuilding UK biotech appeared...
Dominant G-form Spike protein ‘puts its head up’ more frequently to latch on to receptors, but that makes it more vulnerable to neutralization Credit: Los Alamos...
Shares of Inovio climbed in trading after the company announced its DNA vaccine candidate for Covid-19 induced a robust T-cell response against multiple variants of the...
Is more testing really the best way to achieve our aim of living safely with COVID-19?
Variants of the original SARS-CoV-2 are now in wide circulation. That means the third wave of COVID-19 has come with new questions about the variants, their...
3rd Dose Of Pfizer's COVID Vaccine "Likely" Needed To Combat Mutant COVID Strains, CEO Says As American waits for the CDC to finish a review of...
Vaccine Passports Versus Freedom Itself Authored by Paul Alexander via The American Institute for Economic Research, To reject the creeping totalitarianism and dictatorship is the lifeblood...
I don’t see much discussion in the media of an issue that will soon take front and center stage. In America, over 700 people die of...
A phase 3 trial of Romark’s antiviral drug NT-300 has missed the main objective in a phase 3 The post Romark eyes FDA okay for COVID...
Brazil’s richest and most populous state, Sao Paulo, warned its ability to care for seriously ill Covid-19 patients was on the verge of collapse as it...
The first study to directly compare immune reactions between Pfizer’s and AstraZeneca’s Covid-19 vaccines found strong and broadly similar antibody responses in over-80-year-olds after a first...
The one-dose vaccine developed by Johnson & Johnson is temporarily halted because of potentially serious blood clots seen in six women. An immunologist explains what this...
Findings could lead to public health breakthrough for monitoring pandemics Credit: Photo courtesy Louisville/Jefferson County Metropolitan Sewer District. LOUISVILLE, Ky. – The University of Louisville has...
Immunosuppressive drugs for inflammatory diseases like rheumatoid arthritis, multiple sclerosis and ulcerative colitis can impair the body's response to the Covid-19 vaccines from Pfizer/BioNTech and Moderna,...
Paris-based Sanofi bought Cambridge, Massachusetts-based Tidal Therapeutics in a deal totaling $470 million.
Hope that AstraZeneca’s diabetes and heart failure drug Farxiga might treat patients hospitalised with COVID-19 have been dashed
Regeneron is to ask the FDA for clearance to use its antibody cocktail as a preventive treatment for The post Regeneron’s antibody cocktail hits target in...
With changing recommendations about AstraZeneca's COVID-19 vaccine making headlines, many people have questions about its use.
The mechanisms behind vaccine-related and pill-related clots are quite different.
A follow-up study of 33 people who received Moderna Inc.'s Covid-19 vaccine in early trials show the antibodies it induced are still present six months after...
Recently in the spotlight for its role in the Pfizer and Moderna COVID-19 vaccines, mRNA is not a new invention. It's a crucial messenger molecule at...
Credit: Purdue University photo/ Rebecca McElhoe WEST LAFAYETTE, Ind. – New insights into the immune response to SARS-CoV-2 infections could bring better treatments for COVID-19 cases....
New findings and novel technology could inform COVID-19 treatment and vaccine-development efforts Credit: National Institute of Allergy and Infectious Diseases/NIH, 2020 Two studies published in the...
As the US vaccinates millions more people each day, the novel coronavirus works to survive. It does this by mutating. So far, several variants are worrisome....
Credit: Ludvig Kostyal Eight months after mild COVID-19, one in ten people still has at least one moderate to severe symptom that is perceived as having...
Portable platform detects early biomarkers of the Ebola virus faster than PCR, the current industry standard Credit: Michaela Kane, Duke University DURHAM, N.C. — An interdisciplinary...